Document Detail

Randomized controlled trial of early compared with delayed use of inhaled nitric oxide in newborns with a moderate respiratory failure and pulmonary hypertension.
MedLine Citation:
PMID:  19890345     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To evaluate whether early treatment with inhaled nitric oxide (iNO) will prevent newborns with moderate respiratory failure from developing severe hypoxemic respiratory failure (oxygenation index (OI)>or=40). STUDY DESIGN: A total of 56 newborns with moderate respiratory failure (OI between 10 and 30) were randomized before 48 h after birth to early treatment with 20 p.p.m. of iNO (Early iNO group, n=28) or conventional mechanical ventilation with FiO(2) 1.0 (Control group, n=28). Infants received iNO and/or high-frequency oscillatory ventilation (HFOV) if they developed an OI>40. RESULT: 7 of 28 early iNO patients (25%) compared to 17 of 28 control patients (61%) developed an OI>40 (P<0.05). In the Early iNO group mean OI significantly decreased from 22 (baseline) to 19 at 4 h (P<0.05) and remained lower over time: 19 (12 h), 18 (24 h) and 16 at 48 h. In contrast, OI increased in the Control group and remained significantly higher than the Early iNO group during the first 48 h of study: 22 (baseline), 29, 35, 32 and 23 at 4, 12, 24 and 48 h, respectively (P<0.01). Of 17, 6 control patients who developed an OI>40 were successfully treated with iNO. Nine of the remaining eleven control patients and six of seven Early iNO patients who had an OI>40 despite use of iNO responded with the addition of HFOV. One patient of the Early iNO group and two of the Control group died. Median (range) duration of oxygen therapy was significantly shorter in the Early iNO group: 11.5 (5 to 90) days compared to 18 (6 to 142) days of the Control group (P<0.03). CONCLUSION: Early use of iNO in newborns with moderate respiratory failure improves oxygenation and decreases the probability of developing severe hypoxemic respiratory failure.
A González; J Fabres; I D'Apremont; G Urcelay; M Avaca; C Gandolfi; J Kattan
Related Documents :
24174695 - Evaluation of the adequacy of general anesthesia in cesarean section by bispectral index.
23228215 - The effect of hes (130/0.4) usage as the priming solution on renal function in children...
24460975 - A comparison of three techniques (local anesthetic deposited circumferential to vs. abo...
4066735 - Assessment of transcutaneous oxygen tension in ischaemic legs by means of using an elec...
25119055 - Radiological outcomes of pinless navigation in total knee arthroplasty: a randomized co...
18352765 - Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome fo...
Publication Detail:
Type:  Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2009-11-05
Journal Detail:
Title:  Journal of perinatology : official journal of the California Perinatal Association     Volume:  30     ISSN:  1476-5543     ISO Abbreviation:  J Perinatol     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-28     Completed Date:  2010-09-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8501884     Medline TA:  J Perinatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  420-4     Citation Subset:  IM    
Division of Neonatology, Hospital Clínico Universidad Católica, Santiago, Chile.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Inhalation
Anoxia / prevention & control*
High-Frequency Ventilation*
Infant, Newborn
Nitric Oxide / administration & dosage*
Persistent Fetal Circulation Syndrome / complications,  therapy*
Respiratory Insufficiency / etiology,  prevention & control*
Survival Analysis
Reg. No./Substance:
10102-43-9/Nitric Oxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Oxygen saturation trends in preterm infants during the first 15 min after birth.
Next Document:  Genome-wide association study of generalized vitiligo in an isolated European founder population ide...